FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947448571> ?p ?o ?g. }

• W2947448571 abstract "e18015 Background: The steady trend towards outpatient antineoplastic medication delivery has been spurred by improvements in supportive care, innovations in drug delivery, and financial considerations. Despite these trends, a significant number of patients (pts) continue to receive IP Rx for both hematological (HM) and solid cancers (ST). The purpose of this study is to describe a single center’s experience with IP Rx between 01/01/2015 and 12/31/2017. Methods: All pts ( > 18yo) who received IP Rx for a cancer diagnosis, exclusive of stem cell transplantation, were identified from hospital pharmacy records. Patient and disease characteristics were collected at the index (initial) admission. All pts were followed for 1 year after index admission for 30-day readmission and subsequent admissions for IP Rx. Reasons for IP Rx included: urgent/emergent initiation of Rx; high acuity inpatient management for ST (e.g., intraperitoneal, intra-arterial, intravesical therapy) or complex HM regimen; ongoing Rx; palliation. Results: A total of 266 index admissions were identified with 66.2% of pts having a HM (n = 176) and 33.8% having a ST (n = 90). IP Rx was classified as urgent for 48.1% of pts (n = 128); 70.3% (n = 90) of these admissions were new diagnoses of which 91.4% (n = 86) were HM. High acuity IP management was required for 37.5% of pts (n = 100) (47% for ST (n = 47) and 53% for HM (n = 53)). The remaining index admissions were classified as ongoing Rx for 4.5% of pts (n = 12) and palliation for 9.8% (n = 26). Pts with ST required intensive care significantly more often than pts with HM (57.8% vs. 15.9%, p < 0.001) but with no difference in inpatient mortality (4.4% vs. 5.7%, p = 0.891). The 30-day readmission rate was 32.2% for ST and 25.6% for HM (p = 0.515). After the index admission, 10% of ST pts and 60.2% of HM pts had at least 1 subsequent admission for IP Rx (p < 0.001). Conclusions: In this 3-year retrospective review, the vast majority of pts receiving IP Rx required either urgent initiation of care or high acuity care, currently only available in the inpatient setting. While there is little evidence of routine IP Rx or opportunity, at present, to transition further care to the outpatient setting, the high rates of 30-day readmission warrant further evaluation." @default.
• W2947448571 created "2019-06-07" @default.
• W2947448571 creator A5000172588 @default.
• W2947448571 creator A5023064593 @default.
• W2947448571 creator A5024203809 @default.
• W2947448571 creator A5044236743 @default.
• W2947448571 creator A5055169462 @default.
• W2947448571 creator A5062702043 @default.
• W2947448571 creator A5069483381 @default.
• W2947448571 creator A5072501176 @default.
• W2947448571 creator A5064609874 @default.
• W2947448571 date "2019-05-20" @default.
• W2947448571 modified "2023-09-27" @default.
• W2947448571 title "Contemporary use of inpatient antineoplastic (IP) treatment (Rx): Who is getting care and why?" @default.
• W2947448571 doi "https://doi.org/10.1200/jco.2019.37.15_suppl.e18015" @default.
• W2947448571 hasPublicationYear "2019" @default.
• W2947448571 type Work @default.
• W2947448571 sameAs 2947448571 @default.
• W2947448571 citedByCount "0" @default.
• W2947448571 crossrefType "journal-article" @default.
• W2947448571 hasAuthorship W2947448571A5000172588 @default.
• W2947448571 hasAuthorship W2947448571A5023064593 @default.
• W2947448571 hasAuthorship W2947448571A5024203809 @default.
• W2947448571 hasAuthorship W2947448571A5044236743 @default.
• W2947448571 hasAuthorship W2947448571A5055169462 @default.
• W2947448571 hasAuthorship W2947448571A5062702043 @default.
• W2947448571 hasAuthorship W2947448571A5064609874 @default.
• W2947448571 hasAuthorship W2947448571A5069483381 @default.
• W2947448571 hasAuthorship W2947448571A5072501176 @default.
• W2947448571 hasConcept C121608353 @default.
• W2947448571 hasConcept C126322002 @default.
• W2947448571 hasConcept C160735492 @default.
• W2947448571 hasConcept C162324750 @default.
• W2947448571 hasConcept C177713679 @default.
• W2947448571 hasConcept C2775909303 @default.
• W2947448571 hasConcept C2909231917 @default.
• W2947448571 hasConcept C3019816032 @default.
• W2947448571 hasConcept C50522688 @default.
• W2947448571 hasConcept C512399662 @default.
• W2947448571 hasConcept C71924100 @default.
• W2947448571 hasConcept C98274493 @default.
• W2947448571 hasConceptScore W2947448571C121608353 @default.
• W2947448571 hasConceptScore W2947448571C126322002 @default.
• W2947448571 hasConceptScore W2947448571C160735492 @default.
• W2947448571 hasConceptScore W2947448571C162324750 @default.
• W2947448571 hasConceptScore W2947448571C177713679 @default.
• W2947448571 hasConceptScore W2947448571C2775909303 @default.
• W2947448571 hasConceptScore W2947448571C2909231917 @default.
• W2947448571 hasConceptScore W2947448571C3019816032 @default.
• W2947448571 hasConceptScore W2947448571C50522688 @default.
• W2947448571 hasConceptScore W2947448571C512399662 @default.
• W2947448571 hasConceptScore W2947448571C71924100 @default.
• W2947448571 hasConceptScore W2947448571C98274493 @default.
• W2947448571 hasLocation W29474485711 @default.
• W2947448571 hasOpenAccess W2947448571 @default.
• W2947448571 hasPrimaryLocation W29474485711 @default.
• W2947448571 hasRelatedWork W126221856 @default.
• W2947448571 hasRelatedWork W1914674376 @default.
• W2947448571 hasRelatedWork W2041938544 @default.
• W2947448571 hasRelatedWork W2053309871 @default.
• W2947448571 hasRelatedWork W2095905384 @default.
• W2947448571 hasRelatedWork W2108226320 @default.
• W2947448571 hasRelatedWork W2148861397 @default.
• W2947448571 hasRelatedWork W2185944767 @default.
• W2947448571 hasRelatedWork W2286038682 @default.
• W2947448571 hasRelatedWork W2372003628 @default.
• W2947448571 hasRelatedWork W2463636638 @default.
• W2947448571 hasRelatedWork W2786511063 @default.
• W2947448571 hasRelatedWork W2890202871 @default.
• W2947448571 hasRelatedWork W2899013808 @default.
• W2947448571 hasRelatedWork W2991304003 @default.
• W2947448571 hasRelatedWork W3001920871 @default.
• W2947448571 hasRelatedWork W3048012709 @default.
• W2947448571 hasRelatedWork W3112870093 @default.
• W2947448571 hasRelatedWork W2169711751 @default.
• W2947448571 hasRelatedWork W3121328887 @default.
• W2947448571 isParatext "false" @default.
• W2947448571 isRetracted "false" @default.
• W2947448571 magId "2947448571" @default.
• W2947448571 workType "article" @default.